CellSource Co., Ltd.

Tokyo Stock Exchange 4880.T

CellSource Co., Ltd. Free Cash Flow Yield on January 31, 2025: 2.97%

CellSource Co., Ltd. Free Cash Flow Yield is 2.97% on January 31, 2025, a 55.26% change year over year. Free cash flow yield compares the return from free cash flow to the market cap; higher yield suggests attractive investment.

CellSource Co., Ltd. 52-week high Free Cash Flow Yield is 3.30% on January 17, 2025, which is 11.19% above the current Free Cash Flow Yield.
CellSource Co., Ltd. 52-week low Free Cash Flow Yield is 1.50% on August 26, 2024, which is -49.31% below the current Free Cash Flow Yield.
CellSource Co., Ltd. average Free Cash Flow Yield for the last 52 weeks is 2.02%.

Key data

Date	Free Cash Flow Yield	Market Value Added (MVA)	Price to Book Ratio (P/B)	Price to Earnings Ratio (P/E)

Tokyo Stock Exchange: 4880.T

CellSource Co., Ltd.

CEO	Mr. Takashi Sawada
IPO Date	Oct. 29, 2019
Location	Japan
Headquarters	Shibuya Mitake Building
Employees	151
Sector	Health Care
Industries Biotechnology Pharmaceuticals

Description

CellSource Co., Ltd. engages in the regenerative medicine-related and consumer businesses. It also offers Signalift, an anti-aging product. The company was incorporated in 2015 and is headquartered in Tokyo, Japan.

Key trends

Past 5 years